Combined effect of hepatic venous pressure gradient and liver stiffness on long-term mortality in patients with cirrhosis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Both hepatic venous pressure gradient (HVPG) and liver stiffness (LS) are useful tools for predicting mortality in patients with cirrhosis. We investigated the combined effect of HVPG and LS on long-term mortality in patients with cirrhosis. Methods: We retrospectively collected data from 103 patients with cirrhosis, whose HVPG and LS were measured between November 2009 and September 2013. The patients were divided into four groups according to the results of the HVPG and LS measurements. Long-term mortality and the risk factors for mortality were analyzed. Results: Of the 103 patients, 35 were in group 1 (low HVPG and low LS), 16 in group 2 (high HVPG and low LS), 24 in group 3 (low HVPG and high LS), and 28 in group 4 (high HVPG and high LS). Over a median follow-up of 47.3 months, 18 patients died. The mortality rate of patients in group 4 was significantly higher than in the other three groups (vs. group 1, p = 0.005; vs. group 2, p = 0.049; vs. group 3, p = 0.004), but there were no significant differences in survival between groups 1, 2, and 3. In multivariable analyses, both HVPG and LS were identified as independent risk factors for mortality (hazard ratio [HR], 1.127, p = 0.018; and HR, 1.062, p = 0.009, respectively). Conclusions: In patients with cirrhosis, those with concurrent elevation of HVPG and LS had the highest long-term mortality rates. However, when either HVPG or LS alone was elevated, mortality did not increase significantly.
Abstract
Background/Aims: Both hepatic venous pressure gradient (HVPG) and liver stiffness (LS) are useful tools for predicting mortality in patients with cirrhosis. We investigated the combined effect of HVPG and LS on long-term mortality in patients with cirrhosis. Methods: We retrospectively collected data from 103 patients with cirrhosis, whose HVPG and LS were measured between November 2009 and September 2013. The patients were divided into four groups according to the results of the HVPG and LS measurements. Long-term mortality and the risk factors for mortality were analyzed. Results: Of the 103 patients, 35 were in group 1 (low HVPG and low LS), 16 in group 2 (high HVPG and low LS), 24 in group 3 (low HVPG and high LS), and 28 in group 4 (high HVPG and high LS). Over a median follow-up of 47.3 months, 18 patients died. The mortality rate of patients in group 4 was significantly higher than in the other three groups (vs. group 1, p = 0.005; vs. group 2, p = 0.049; vs. group 3, p = 0.004), but there were no significant differences in survival between groups 1, 2, and 3. In multivariable analyses, both HVPG and LS were identified as independent risk factors for mortality (hazard ratio [HR], 1.127, p = 0.018; and HR, 1.062, p = 0.009, respectively). Conclusions: In patients with cirrhosis, those with concurrent elevation of HVPG and LS had the highest long-term mortality rates. However, when either HVPG or LS alone was elevated, mortality did not increase significantly.
참고문헌 (42)
- Mokdad AA, "Liver cirrhosis mortality in 187 countries between 1980 and 2010 : a systematic analysis", BMC Med, 12, pp.145~ (2014)
- Braet F, "Structural and functional aspects of liver sinusoidal endothelial cell fenestrae : a review", Comp Hepatol, 1, pp.1~ (2002)
- Bravo AA, "Liver biopsy", N Engl J Med, 344, pp.495~500 (2001)
- Regev A, "Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection", Am J Gastroenterol, 97, pp.2614~2618 (2002)
- Ferraioli G, "Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C : a pilot study", Hepatology, 56, pp.2125~2133 (2012)
- Deffieux T, "Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastography", J Hepatol, 62, pp.317~324 (2015)
- Jeong JY, "Real time shear wave elastography in chronic liver diseases : accuracy for predicting liver fibrosis, in comparison with serum markers", World J Gastroenterol, 20, pp.13920~13929 (2014)
- Wong GL, "Prediction of fibrosis progression in chronic viral hepatitis", Clin Mol Hepatol, 20, pp.228~236 (2014)
- Berzigotti A, "Non-invasive evaluation of portal hypertension using ultrasound elastography", J Hepatol, 67, pp.399~411 (2017)
- Pang JX, "Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease", PLoS One, 9, pp.e95776~ (2014)
- Singh S, "Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases : a systematic review and meta-analysis", Clin Gastroenterol Hepatol, 11, pp.1573~1584 (2013)
- Kim TY, "Diagnostic performance of shear wave elastography for predicting esophageal varices in patients with compensated liver cirrhosis", J Ultrasound Med, 35, pp.1373~1381 (2016)
- Xu X, "Performance of transient elastography assessing fibrosis of single hepatitis B virus infection : a systematic review and meta-analysis of a diagnostic test", Hepatol Int, 9, pp.558~566 (2015)
- 정우경, "Principles and clinical application of ultrasound elastography for diffuse liver disease", ULTRASONOGRAPHY, 33(3), pp.149~160 (2014), 대한초음파의학회
- Poynard T, "Liver fibrosis evaluation using real-time shear wave elastography : applicability and diagnostic performance using methods without a gold standard", J Hepatol, 58, pp.928~935 (2013)
- Ripoll C, "Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis", Gastroenterology, 133, pp.481~488 (2007)
- Merkel C, "Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices", Gastroenterology, 102, pp.973~979 (1992)
- Ripoll C, "Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era", Hepatology, 42, pp.793~801 (2005)
- 손주현, "Hepatic Venous Pressure Gradient Predicts Long-Term Mortality in Patients with Decompensated Cirrhosis", Yonsei Medical Journal, 57(1), pp.138~145 (2016), 연세대학교의과대학[DOI]
- Merkel C, "The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis", Hepatology, 32, pp.930~934 (2000)
- La Mura V, "Cirrhosis and portal hypertension : the importance of risk stratification, the role of hepatic venous pressure gradient measurement", World J Hepatol, 7, pp.688~695 (2015)
- Bosch J, "Measurement of portal pressure and its role in the management of chronic liver disease", Semin Liver Dis, 26, pp.348~362 (2006)
- 김가은, "Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis", Clinical and Molecular Hepatology, 23(1), pp.34~41 (2017), 대한간학회[DOI]
- Kumar A, "Correlation of transient elastography with hepatic venous pressure gradient in patients with cirrhotic portal hypertension : a study of 326 patients from India", World J Gastroenterol, 23, pp.687~696 (2017)
- Kim TY, "Evaluation of portal hypertension by real-time shear wave elastography in cirrhotic patients", Liver Int, 35, pp.2416~2424 (2015)
- Castera L, "Non invasive evaluation of portal hypertension using transient elastography", J Hepatol, 56, pp.696~703 (2012)
- Colecchia A, "Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients : a review of the literature", Eur J Gastroenterol Hepatol, 27, pp.992~1001 (2015)
- Child CG, "Surgery and portal hypertension", Major Probl Clin Surg, 1, pp.1~85 (1964)
- Kamath PS, "A model to predict survival in patients with end-stage liver disease", Hepatology, 33, pp.464~470 (2001)
- European Association for the Study of the Liver, "EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis", J Hepatol, 53, pp.397~417 (2010)
- American Association for the Study of Liver Diseases, "Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases", J Hepatol, 61, pp.642~659 (2014)
- Castera L, "Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis", J Viral Hepat, 16, pp.300~314 (2009)
- Joo SK, "Prospective comparison of noninvasive fibrosis assessment to predict advanced fibrosis or cirrhosis in Asian patients with hepatitis C", J Clin Gastroenterol, 49, pp.697~704 (2015)
- McConnell M, "Biology of portal hypertension", Hepatol Int, 12(Suppl 1), pp.11~23 (2018)
- Rockey D, "The cellular pathogenesis of portal hypertension : stellate cell contractility, endothelin, and nitric oxide", Hepatology, 25, pp.2~5 (1997)
- Fernandez M, "Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats", Hepatology, 46, pp.1208~1217 (2007)
- 홍원기, "The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data", Clinical and Molecular Hepatology, 19(4), pp.370~375 (2013), 대한간학회
- Lemoine M, "Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis", Aliment Pharmacol Ther, 28, pp.1102~1110 (2008)
- Chevallier M, "A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens : comparison with morphometric studies", Hepatology, 20, pp.349~355 (1994)
- Thiele M, "Transient and 2-dimensional shear-wave elastography provide comparable assessment of alcoholic liver fibrosis and cirrhosis", Gastroenterology, 150, pp.123~133 (2016)
- Chon YE, "Improvement of liver fibrosis after long-term antiviral therapy assessed by fibroscan in chronic hepatitis B patients with advanced fibrosis", Am J Gastroenterol, 112, pp.882~891 (2017)
- Sandrin L, "Transient elastography : a new noninvasive method for assessment of hepatic fibrosis", Ultrasound Med Biol, 29, pp.1705~1713 (2003)